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Abstract
Purpose To identify risk factors for suboptimal IVF out-
comes using insemination with donor spermatozoa and to
define a lower threshold that may signal a conversion to
fertilization by ICSI rather than insemination.
Method Retrospective, age-matched, case-control study of
women undergoing non-donor oocyte IVF cycles using
either freshly ejaculated (N=138) or cryopreserved donor
spermatozoa (N=69). Associations between method of
fertilization, semen sample parameters, and pregnancy rates
were analyzed.
Results In vitro fertilization of oocytes with donor
spermatozoa by insemination results in equivalent fertil-
ization and pregnancy rates compared to those of freshly
ejaculated spermatozoa from men with normal semen
analyses when the post-processing motility is greater than
or equal to 88%. IVF by insemination with donor
spermatozoa when the post-processing motility is less
than 88% is associated with a 5-fold reduction in
pregnancy rates when compared to those of donor
spermatozoa above this motility threshold. When the
post-processing donor spermatozoa motility is low, fertil-
ization by ICSI is associated with significantly higher
pregnancy rates compared to those of insemination.
Conclusion While ICSI does not need to be categorically
instituted when using donor spermatozoa in IVF, patients
should be counseled that conversion from insemination to
ICSI may be recommended based on low post-processing
motility.
Keywords Donor sperm . Fertilization . ICSI .
Insemination . IVF. Pregnancy
Introduction
Assisted reproductive technology (ART) using cryopre-
served donor spermatozoa is a widely available treatment
for couples with severe male infertility (azoospermia) or
for patients without male partners desiring pregnancy.
While donor spermatozoa are commonly utilized for
intrauterine insemination, concomitant female factors
such as tubal disease or diminished ovarian reserve
may require that donor spermatozoa be used for in vitro
fertilization (IVF). In this setting, there is a paucity of
information on whether intracytoplasmic sperm injection
(ICSI) of cryopreserved donor spermatozoa can increase
fertilization or pregnancy rates when compared to
traditional insemination. As a result, when using donor
spermatozoa, a variety of approaches to practice exist,
with some centers performing insemination while others
recommending ICSI.
The existing literature suggests that the cryopreservation
methods used for the storage of donor spermatozoa do not
significantly compromise pregnancy rates when used to
inseminate oocytes for IVF(1–4). Although both the initial
J Assist Reprod Genet (2009) 26:83–91
DOI 10.1007/s10815-008-9291-5
Capsule In vitro fertilization of oocytes with donor spermatozoa by
insemination results in equivalent fertilization and pregnancy rates
compared to those of freshly ejaculated spermatozoa from men with
normal semen analyses when the post-processing motility is greater
than or equal to 88%. Below this threshold, pregnancy rates are low,
and ICSI should be considered.
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and post-processing concentration and motility of donor
spermatozoa are generally lower than those of freshly
ejaculated spermatozoa, it is believed that the impact on
pregnancy rates is negligible. Nonetheless, the concentra-
tion and motility of donor spermatozoa can vary widely
upon thawing. At this time, there are no known
parameters to identify those at risk of poor treatment
outcomes. Thus, when a mild to moderately abnormal
donor specimen is encountered post-thaw, the decision to
convert from insemination to ICSI remains relatively
subjective.
In this study, we retrospectively compared the fertiliza-
tion rates and pregnancy outcomes of IVF cycles that used
donor spermatozoa for oocyte insemination against rates
obtained during routine IVF in which freshly ejaculated
spermatozoa from men without male factor infertility was
used. Our aims were to identify predictors of poor
outcomes with donor spermatozoa and to define a lower
threshold that may signal a conversion to fertilization by
ICSI rather than insemination. Lastly, we attempted to
verify the efficacy of ICSI by comparing the outcomes of
those IVF cycles identified to be at risk for poor outcomes
using insemination to those of cycles in which ICSI was
utilized because of similar risks factors.
Materials and methods
During the time period between January 1, 2006 and
December 31, 2007, all cases of fresh non-donor oocyte
IVF cycles using commercially purchased donor spermato-
zoa for traditional insemination or ICSI were retrospective-
ly identified. All donor semen were obtained from sperm
banks and prepared using standard cryopreservation tech-
niques intended for intra-cervical insemination (ICI).
Clinical indications included male partners with non-
obstructive azoospermia, same sex couples, and single
women without male partners desiring pregnancy.
IVF cycle information for all cases and controls were
jointly stored in a clinical database chronologically sorted
by cycle start dates. For each case of IVF using insemina-
tion with donor spermatozoa (Group A), the next two
controls in the database (Group B) who matched the
identified case by age were included in the analysis for
comparison . Controls were selected from patients who
underwent fresh non-donor oocyte IVF cycles with insem-
ination of freshly ejaculated spermatozoa obtained from
their male partners (Fig. 1). Semen analyses for all male
partners were performed by the same andrology laboratory
prior to the IVF cycle and showed concentrations greater
Fig. 1 Patient-group flow chart. Between 2006–2007, there were 111
fresh non-donor oocyte IVF cycles that used commercial donor
spermatozoa. Of these cycles, fertilization occurred by routine
insemination in 69 cycles (Group A) and by ICSI in 42 cycles. The
age-matched control group consisted of 138 (2:1 ratio) cycles of fresh
non-donor oocyte IVF during the same time period that used freshly
ejaculated spermatozoa (Group B). Fertilization in the control group
also occurred by insemination, and normal semen analyses were
documented in the male partners prior to the treatment cycle. Post-
processing motility of less than 88% was identified as a possible
predictor of poor pregnancy outcomes when using donor spermatozoa
for insemination in IVF cycles. Group A was divided into those with
post-processing motility of ≥88% (Group A1) and those with <88%
(Group A2) for further analysis. Of the 42 cases of IVF using donor
spermatozoa where insemination was converted to ICSI based on the
recommendation of the andrologists, there were 36 cases where the
post-processing motility was <88% (Group C). The remaining six
cases were excluded from the analysis because the post-processing
spermatozoa motility was greater than or equal to 88% in each case
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than 20 million spermatozoa per milliliter, motility greater
than 50%, and Kruger morphology greater than 14%. Case-
control matching by age and by cycle start date was
intended to minimize the potential biases resulting from
age-associated decline in oocyte quantity and quality and
from unrecognized temporal variations in laboratory and
culture conditions, respectively.
Additionally, all cases of IVF using donor spermatozoa
where conversion from insemination to ICSI as a result of
suboptimal post-thaw spermatozoa parameters were identi-
fied from the same study period (Fig. 1). Since no uniform
criteria for poor quality donor specimen were objectively
defined during this time, recommendations for conversion
to ICSI in these cases were based on the clinical experience
of the andrologists.
Standard protocols for controlled ovarian hyperstimula-
tion (COH) with gonadotropins were used for all patients.
Pituitary suppression was achieved either with two weeks
of leuprolide acetate preceding COH or with a GnRH
antagonist administered after five days of COH. Follicular
monitoring was performed using serial transvaginal ultra-
sound and serum estradiol levels. 10,000 units of human
chorionic gonadotropin (hCG) were administered when at
least three follicles reached a diameter of eighteen milli-
meters or greater, and transvaginal ultrasound guided
oocyte pick-up was performed 34–36 h later.
Freshly ejaculated as well as previously cryopreserved
donor spermatozoa were routinely prepared by separation
on a density gradient and/or by swim-up from a washed
pellet. A standard concentration of 0.1×106 motile sperma-
tozoa/ml was used to inseminate the oocytes. Fertilization
results were verified within 16–18 h after insemination or
microinjection. Embryos were cultured to either the
cleavage or the blastocyst stage in proprietary culture
medias for day three or day five embryo transfers,
respectively. Clinical pregnancy was defined by the
presence of a gestational sac on transvaginal ultrasound
approximately four weeks after embryo transfer.
Patient age, stimulation, fertilization, and pregnancy
outcomes, as well as initial and post-processing spermato-
zoa parameters were compared between IVF cycles using
donor (Group A) and freshly ejaculated spermatozoa
(Group B) for oocyte insemination. All continuous varia-
bles are summarized as medians with interquartile ranges
and compared by the Wilcoxon signed-rank test. Dichoto-
mous outcomes are expressed as percentages with standard
deviations and compared using χ2 or Fisher’s exact test
when appropriate.
To identify potential associations between spermatozoa
quality and treatment outcomes, the initial and post-
processing spermatozoa parameters for Groups A and B
were collectively stratified and compared by pregnancy
outcomes using the Wilcoxon signed-rank test. In addition,
multivariate logistic regression was performed to confirm
the predictive value of these parameters controlling for
potential confounders. Receiver operating characteristics
(ROC) curve and cross tabulation were performed to further
define the optimal discriminatory values for the statistically
significant covariates.
Finally, the efficacy of ICSI in the setting of suboptimal
donor spermatozoa parameters was evaluated by comparing
the outcomes of the IVF cycles using donor spermatozoa
insemination that were identified to be at the greatest risk
for poor pregnancy outcomes to those of a similar patient
group whose oocytes were fertilized by intracytoplasmic
injection (ICSI) with donor spermatozoa (Group C).
Results
During the study period, there were 69 fresh IVF cycles in
which non-donor oocytes were fertilized by insemination
with donor spermatozoa (Group A). Using a two to one
case-control ratio, 138 women matched by age and cycle
start date who underwent fresh non-donor IVF cycles using
freshly ejaculated spermatozoa from their partners (Group
B) were selected for comparison (Fig. 1). There were no
significant differences between the two groups in terms of
age. In addition, the total number of oocytes and the
number of mature oocytes retrieved were equivalent
(Table 1).
The initial concentration (p<0.0001), motility (p<
0.0001) and the total number of motile spermatozoa (p<
0.0001) were significantly greater in the freshly ejaculated
semen compared to those of donor specimens. After
processing by swim-up and/or density gradients, higher
concentration (p<0.0001), motility (p<0.0001), and total
motile spermatozoa count (p<0.0001) were obtained from
freshly ejaculated semen compared to those obtained for
cryopreserved donor specimens.
Despite the significant differences in spermatozoa
parameters, the rates of total and normal fertilization were
equivalent between the two groups. IVF cycles using
insemination with donor spermatozoa were associated with
a significantly greater risk of having no suitable embryos
for transfer compared to those cycles inseminated with
freshly ejaculated spermatozoa (18.8±4.7% vs. 7.2±2.2%,
p<0.028). Nevertheless, the number of embryos transferred
was equivalent and the pregnancy rates were similar
between the two groups, whether adjusted by per retrieval
or per embryo transfer. The likelihood of having day five
blastocyst transfers was also equivalent.
In the univariate analysis combining donor spermatozoa
(Group A) and freshly ejaculated partner sperm (Group B),
cycles resulting in pregnancies were associated with higher
initial total motile spermatozoa count (p<0.021) and post-
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processing motility (p<0.012) compared to those of cycles
that did not result in pregnancies (Table 2). None of the
other spermatozoa parameters showed significant associations
with pregnancy outcomes. In a multivariate logistic regression
model predicting pregnancy outcomes (data not shown), these
two covariates, initial total motile spermatozoa (p<0.017) and
post processing motility (p<0.030), remained statistically
significant after adjusting for potential confounders such as
age, method of pituitary suppression, number of mature
oocytes, donor versus partner spermatozoa, blastocyst
transfer, and the number of embryos transferred.
Using ROC curves, the initial total motile spermatozoa
count demonstrated a significant but low area under the
curve (AUC) for predicting pregnancy outcomes (Fig. 2A:
AUC=0.602, p<0.017). The discriminatory value of the
initial total motile spermatozoa was limited to cycles
inseminated with freshly ejaculated spermatozoa (Fig. 2B:
AUC=0.643, p<0.006) and not statistically significant in
cycles inseminated with donor spermatozoa (Fig. 2C:
AUC=0.548, p=NS). In terms of the post-processing
motility, the overall AUC combining all IVF cycles
inseminated with either donor or partner spermatozoa was
also significantly different from 0.5 (Fig. 2D: AUC=0.595,
p<0.025) for predicting pregnancy outcomes. However, the
post-processing motility only had a significant discrimina-
tory value in donor spermatozoa cycles (Fig. 2F: AUC=
0.731, p<0.002) and not in IVF cycles inseminated with
freshly ejaculated spermatozoa (Fig. 2E: AUC=0.578, p=
NS). A threshold value of 88% in the post-processing donor









Initial concentration (million/ml) 42 (31–62) 47 (33–81) .194
Initial motility (%) 56 (45–62) 58 (48–67) .055
Initial total motile count (million) 40 (13–76) 53 (19–104) .021
Post-processing concentration
(million/ml)
6 (4–9) 6 (4–10) .953
Post-processing motility (%) 94 (89–98) 96 (93–99) .012
Post-processing total motile count
(million)
2 (1–6) 3 (1–6) .278
Summary statistics are expressed in median and interquartile range
and compared using the Wilcoxon signed-ranked test unless otherwise
specified
Table 1 Patient characteristics, stimulation, fertilization, and pregnancy outcomes for cycles using partner versus donor Spermatozoa (median,
interquartile range)
(A) (B)
Spermatozoa Source Donor Freshly Ejaculated
Fertilization Method Insemination Insemination
N=69 N=138 P-Value
Age 40 (38–42) 40 (37–42) 0.66
Percentage of cycles using GnRH Antagonist * 76.8±5.1 79.1±3.5 0.71
Number of oocytes retrieved 10 (6–15) 11 (7–16) 0.59
Number of mature oocytes 9 (6–14) 10 (6–15) 0.80
Spermatozoa parameters
Initial concentration (million/ml) 38 (29–46) 50 (34–87) 0.0001
Initial motility (%) 44 (34–51) 60 (53–68) 0.0001
Initial total motile spermatozoa (million) 11 (8–16) 68 (41–101) 0.0001
Post-processing concentration (million/ml) 4 (3–7) 7 (5–10) 0.0001
Post-processing motility (%) 90 (85–93) 97 (94–100) 0.0001
Post-processing total motile spermatozoa (million) 1.0 (0.6–1.4) 4.6 (2.4–9.7) 0.0001
Fertilization rates
Total (%) 86 (63–100) 86 (75–100) 0.94
Normal (%) 73 (50–83) 73 (57–83) 0.30
Outcomes
Percentage of cycles without suitable embryos for transfer* 18.8±4.7 7.2±2.2 0.02
Percentage of cycles resulting in day 5 embryo transfers* 23.2±5.7 18.5±3.4 0.54
Number of embryos transferred 3 (2–4) 3 (3–4) 0.22
Pregnancy rate per retrieval (%)* 33.3±5.7 31.9±4.0 1.00
Pregnancy rate per embryo transfer (%)* 41.1±6.6 34.9±4.2 0.16
Summary statistics are expressed in median and interquartile range and compared using the Wilcoxon signed-ranked test unless otherwise
specified, *Pearson χ2 test
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spermatozoa motility was associated with a sensitivity of
80% and a specificity of 70% for predicting positive and
negative pregnancy outcomes, respectively (Fig. 2F).
When the 69 IVF cycles using insemination with donor
spermatozoa were analyzed by the post processing sperma-
tozoa motility, 45 cycles (Group A1) had motility greater
than or equal to 88% while 24 cycles (Group A2) had
motility less than the threshold value of 88% defined by the
ROC curve (Table 3). The mean age and the number of
mature oocytes did not differ significantly between the two
groups. The rates of normal fertilization were the same
despite the difference in the post-processing motility.
Although there were no significant differences in the
number of embryos transferred, the pregnancy rate per
retrieval was significantly lower when post processing
donor spermatozoa with less than 88% motility were used
for insemination compared to those of cycles inseminated
with post-processing spermatozoa motility between 88–
Fig. 2 Receiver Operating
Characteristic Curves for Pre-
dicting Pregnancy Outcomes
with Initial Total Motile Sper-
matozoa Count and
Post-processing Motility. (A)
Combining all IVF cycles using
donor and partner spermatozoa
for oocyte insemination, the ini-
tial total motile spermatozoa
count demonstrated an area un-
der the curve (AUC) of 0.602
for predicting pregnancy out-
comes, significantly different
from 0.5 (p<0.017). In the sub-
group analyses, the discrimina-
tory value was only significant
in cycles using freshly ejaculat-
ed spermatozoa (B), with an
AUC=0.643 (p<0.006). The
AUC in cycles using donor
spermatozoa (C) was 0.548 (p=
NS). The post-processing motil-
ity also demonstrated significant
discriminatory value (AUC=
0.595, p<0.025) for both groups
combined (D). However, the
AUC of 0.578 was not signifi-
cant in the freshly ejaculated
spermatozoa subgroup (E). For
donor spermatozoa, post pro-
cessing motility demonstrated a
relatively high discriminatory
value with an AUC of 0.731
(p<0.002). A threshold value of
88% in motility was associated
with 80% sensitivity for positive
pregnancy and 70% specificity
for negative pregnancy
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100% (8.3±5.8% vs. 46.6±7.5%, p<0.001). The differ-
ences were still significant when pregnancy rates were
adjusted by per embryo transfer (11.1±7.6% vs. 55.2±
8.2%, p<0.002).
Of the 42 identified cases of IVF using donor sperma-
tozoa where insemination was converted to ICSI based on
the recommendation of the andrologists (Fig. 1), there were
36 cases where the post-processing motility was less than
88% (Group C). Compared to the 24 IVF cycles where the
oocytes were inseminated with donor spermatozoa with
motility less than 88% in the final preparation (Group A2),
pregnancy rates were significantly higher per retrieval (p<
0.001) and per embryo transfer (p<0.004) in the ICSI group
despite similar mean age, number of mature oocytes
retrieved, rates of normal fertilization, and number of
embryos transferred between the two groups (Table 4).
Discussion
Consistent with prior studies [1, 2], cryopreserved donor
spermatozoa had lower initial concentration, motility, and
Table 4 Comparison of fertilization and pregnancy outcomes by methods of fertilization with low post-processing semen motility
(A2) (C)
Spermatozoa source Donor Donor
Method of fertilization Insemination ICSI
Post-processing semen motility <88% <88%
N=24 N=36 p-value
Age 41 (38–42) 40 (35–42) 0.087
Mature oocytes retrieved 10 (7–15) 10 (5–17) 0.111
Outcomes
Normal fertilization rate (%) 64 (32–85) 80 (64–89) 0.767
Percentage of cycles without suitable embryos for transfer (%)* 25.0±9.0 8.3±4.7 0.079
Number of embryos transferred 3 (2–3) 3 (2–4) 0.431
Pregnancy rate per retrieval* 8.3±5.8 47.2±8.4 0.001
(2/24) (17/36)
Pregnancy rate per embryo transfer* 11.1±7.6 51.5±8.8 0.004
(2/18) (17/33)
Summary statistics are expressed in median and interquartile range and compared using the Wilcoxon signed-ranked test unless otherwise
specified, *Fisher’s exact test
Table 3 Comparison of fertilization and pregnancy outcomes by post-processing Spermatozoa motility
(A1) (A2)
Spermatozoa source Donor Donor
Method of fertilization Insemination Insemination
Post-processing semen motility ≥88% <88%
N=45 N=24 p-value
Age 40 (38–42) 41 (38–42) 0.98
Mature oocytes retrieved 10 (6–15) 10 (7–15) 0.85
Outcomes
Normal fertilization rate (%) 75 (60–83) 64 (32–85) 0.177
Percentage of cycles without suitable embryos for transfer (%)* 15.5±5.5 25.0±9.0 0.251
Number of embryos transferred 3 (2–4) 3 (2–3) 0.510
Pregnancy rate per retrieval (%)* 46.6±7.5 8.3±5.8 0.001
(21/45) (2/24)
Pregnancy rate per embryo transfer (%)* 55.2±8.2 11.1±7.6 0.002
(21/38) (2/18)
Summary statistics are expressed in median and interquartile range and compared using the Wilcoxon signed-ranked test unless otherwise
specified, *Fisher’s exact test
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total motile count upon thawing when compared to those of
freshly ejaculated semen samples from men with normal
semen analyses. These disparities remained significant even
after processing by separation on density gradients and/or
by swim-up. However, the negative clinical impact of these
lower donor spermatozoa parameters was not apparent in
the general analyses.
Our study confirmed previously published results [5]
that despite the lower concentration and motility, insemi-
nation of oocytes with donor spermatozoa in the setting of
IVF does not result in lower total or normal fertilization
rates compared to cycles using freshly ejaculated semen.
Furthermore, there were no significant differences in the
pregnancy rates observed comparing IVF cycles using
cryopreserved donor to freshly ejaculated spermatozoa.
These findings are also consistent with the results of prior
studies [2, 5–7]. However, the negative findings must be
interpreted with caution since this study did not have
sufficient power to detect pregnancy rate differences less
than 20% between cases and controls due to the limited
number of IVF cycles using donor spermatozoa.
The negative findings from our own and other similar
general statistical analyses [1–4] support the clinical dictum
that in vitro fertilization by insemination is appropriate
when using donor spermatozoa despite the well-recognized
decreases in concentration and motility compared to those
of freshly ejaculated spermatozoa. However, the categorical
acceptance of this approach has precluded the recognition
of signals indicating poor quality donor spermatozoa that
may compromise clinical outcomes. To our knowledge,
there have been no studies to date attempting to identify
cryopreserved donor spermatozoa parameters capable of
discriminating pregnancy outcomes.
The seemingly equivalent pregnancy outcomes between
donor and partner spermatozoa despite widely disparate
post-processing parameters suggest that lower quality donor
spermatozoa either meet the minimal threshold for main-
taining optimal outcome or the differences can be compen-
sated for by adjustments in the processing methods or in the
concentration of the inseminated spermatozoa. However,
this analysis indicates that the initial total motile count and
the post-processing motility of the spermatozoa may
significantly impact pregnancy outcomes. The potential
discriminatory value of these parameters was confirmed by
the logistic regression model after controlling for potential
confounders.
In the ROC curve analyses, initial total motile count had
a significant but small area under the curve. In the subgroup
analysis, discriminatory value of the initial total motile
count was only significant in freshly ejaculated spermato-
zoa but not in cycles using donor spermatozoa. In contrast,
post-processing motility had a significant discriminatory
value in predicting pregnancy outcomes in cycles using
donor spermatozoa but not in cycles using freshly ejaculated
spermatozoa. In the latter group, the median post-processing
motility was 97% with only two percent of the cycles having
motility below 88%. Due to this uniformly high post-
processing motility in the freshly ejaculated spermatozoa,
the parameter would not be expected to significantly
influence pregnancy outcomes in this subgroup.
In IVF cycles using donor spermatozoa insemination, the
ROC curve analysis suggested that a post-processing
motility of 88% provided maximal discrimination of
pregnancy outcomes. Motility values equal to or above this
threshold value provided a sensitivity of 80% for positive
pregnancy, and values below provided a specificity of 70%
for negative pregnancy result. Indeed, the cross-tabulation
results demonstrated that despite starting with equivalent
numbers of mature oocytes and similar rates of normal
fertilization, pregnancy rates were extremely low in the
group inseminated with donor spermatozoa that had less than
88% motility compared to those with greater than or equal to
88%.
Cryopreservation leads to increases in chromatin insta-
bility and single-strand DNA fragmentation [8–10]. Al-
though not investigated in the current analysis, the recent
literature on sperm DNA fragmentation have consistently
demonstrated that the degree of fragmentation strongly
correlates with spermatozoa parameters such as concentra-
tion, motility, and morphology with correlation coefficients
as high as 0.50 [11–15]. Hence it is possible that the post-
processing spermatozoa motility may be an index of cryo-
injury and DNA fragmentation [8].
Although post-processing motility less than 88% is
associated with dramatically reduced pregnancy rates, the
mechanism does not appear to be associated with a
reduction in fertilization rates or in the number of available
embryos for transfer. Interestingly, this observation is
highly consistent with findings from studies analyzing
sperm DNA fragmentation and IVF outcomes. The majority
of those studies demonstrated high sperm DNA fragmen-
tation does not preclude fertilization but negatively impacts
subsequent embryo development and reduces pregnancy
rates [12, 13, 15–17]. The initial steps of embryonic
development from fertilization up to the 6–8 cell cleavage
stage occur essentially independent of the embryonic/
paternal genome and are predominately under the influence
of maternal transcripts packaged into the oocytes at the time
of ovulation [18]. Thus the deleterious effects of abnormal
paternal gene expressions on embryonic development
would not be apparent prior to embryo transfers and likely
inhibit subsequent embryonic development in utero leading
to the reduced pregnancy rates.
Whether the abnormalities associated with post-process-
ing motility of less 88% in donor spermatozoa can be
compensated by ICSI could not be adequately analyzed in
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this study because it was not a uniformly accepted criterion
for conversion from routine insemination to ICSI at our
center during the study period. However, the limited
comparisons between all cases of conversions to ICSI with
post-processing motility less than 88% and insemination
with donor spermatozoa with similarly low post processing
motility suggest that ICSI may provide significant benefits
in improving pregnancy outcomes. Again, the mechanism
does not seem to be directly related to an increase in the
rate of normal fertilization or in the number of available
embryos for transfer. A prospective study using the
criterion established by this analysis is necessary to confirm
the potential benefit of ICSI.
As with all retrospective analyses, our study was limited by
potential confounders and biases despite adequatematching of
baseline characteristics and the use of multiple regression
models to confirm the results of the univariate analyses. In
particular, information on factors that may influence fertiliza-
tion and pregnancy outcomes such as sperm morphology [19–
21] and total progressive motile sperm count [22, 23] was
not available in this study. In addition, the sample size was
limited by the small number of donor spermatozoa IVF
cycles available for analysis. Despite these limitations, the
large magnitude of the association between low post-
processing motility and pregnancy outcomes found in this
study warrants further attention and confirmation in larger
prospective randomized studies.
In summary, our study confirmed that outcomes using
donor spermatozoa for oocyte insemination in the setting
of IVF generally did not differ from that of freshly
ejaculated spermatozoa. However, further analyses iden-
tified post-processing motility of less than 88% in donor
spermatozoa as a potential risk factor for poor outcomes.
Converting from routine insemination to ICSI in these
cases appears to significantly improve outcomes. In our
study population, 56% of the donor spermatozoa had
motility below this threshold value on final processing.
Hence, while ICSI does not need to be categorically
instituted when using donor spermatozoa in IVF, patients
must be counseled in advance regarding the relatively
high likelihood of conversion to ICSI based on the post-
processing motility value.
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